Transcatheter CoreValve valve-in-valve implantation in a stentless porcine aortic valve for severe aortic regurgitation
نویسندگان
چکیده
KEY CLINICAL MESSAGE We describe the first valve-in-valve Corevalve transcatheter aortic valve replacement in the St. Jude Toronto stentless porcine aortic valve in the United States, which enabled this 59-year-old patient with a history of bacterial endocarditis and aortic regurgitation to avoid heart transplant with complete resolution of his severe left ventricular dysfunction.
منابع مشابه
Transcatheter aortic valve-in-valve implantation of a CoreValve in a JenaValve prosthesis: a case report
BACKGROUND Transcatheter aortic valve implantation has become an accepted treatment modality for inoperable or high-risk surgical patients with symptomatic severe aortic stenosis. CASE PRESENTATION We report the case of a 70-year-old white man who was treated for severe symptomatic aortic regurgitation using transcatheter aortic valve implantation from the apical approach. Because of recurren...
متن کاملTranscatheter Aortic Valve Replacement: A Review Article
Transcatheter aortic valve replacement (TAVR) is a novel therapeutic intervention for the replacement of severely stenotic aortic valves in high-risk patients for standard surgical procedures. Since the initial PARTNER trial results, use of TAVR has been on the rise each year. New delivery methods and different valves have been developed and modified in order to promote the minimally invasive p...
متن کاملSevere calcification of a Shelhigh stentless valved conduit.
A 74-year old patient developed severe aortic valve regurgitation 11 years following root replacement using a stentless Shelhigh tube-graft. Computed tomography scan showed a heavily calcified aortic conduit (Fig. 1), although the company claims that detoxification process eliminates residual glutaraldehyde and ensures less calcification in the long term. The patient underwent successful transa...
متن کامل"Balloon withdrawal technique" to correct prosthesis malposition and treat paravalvular aortic regurgitation during TAVI.
Transcatheter aortic valve implantation (TAVI) is an emerging technology used to treat high-risk patients with severe aortic stenosis. During TAVI with the CoreValve ReValving System, a balloon is used for the reduction of paravalvular regurgitation. However, in this paper, we describe the "balloon withdrawal" technique through which the positioning of a second valve can be avoided in case of i...
متن کاملPercutaneous implantation of the self-expandable CoreValve for high risk patients with severe aortic valve stenosis: early Israeli experience.
BACKGROUND The prevalence of aortic stenosis increases with advancing age. Once symptoms occur the prognosis in patients with severe aortic stenosis is poor. The current and recommended treatment of choice for these patients is surgical aortic valve replacement. However, many patients, mainly the very elderly and those with major comorbidities, are considered to be at high surgical risk and are...
متن کامل